Akero Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
21.03.23
/
50%
€34.60
Target price
21.03.24
€53.84
Performance (%)
-31.21%
End price
22.03.24
€23.80
Summary
This prediction ended on 22.03.24 with a price of €23.80. Massive losses of -31.21% were the result for the BUY prediction by Canaccord_Genuity_Gr. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | -6.457% | -6.457% | -55.476% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at Canaccord Genuity Group Inc. from $50.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten